Discounted Cash Flow Rating

Strong Buy

Return on Equity Rating

Sell

Debt to Equity Rating

Neutral

Price to Earnings Rating

Buy

Analyst Rating

Neutral

Simple Moving Average

Neutral

Exponential Moving Average

Neutral

Relative Strength Index

Neutral

Standard Deviation

Strong Sell

Williams %R

Strong Buy

Average Directional Index

Sell

Insider Trading

Neutral

Wall Street Data Solutions Rating

Neutral

B

Achilles Therapeutics plc American Depositary Shares (ACHL)

https://www.achillestx.com

Achilles Therapeutics PLC is a biopharmaceutical company. It is developing novel cancer immunotherapies targeting clonal neoantigens. The company has two ongoing trials, the CHIRON trial in patients with non-small-cell lung cancer and the THETIS trial in patients with recurrent or metastatic melanoma.

Current Price

---.--

% Change Today

0.00%

Change Amt. Today

0.00

Active Status

Active

Listing Date

03/31/2021

Market Cap

30,035,256

Shares Outstanding

40,940,000

Weighted SO

40,782,948

Total Employees

N/A

Upcoming Earnings

08/02/2024

Beta

1.3170

Last Div

0.0000

Range

0.731-1.76

Chg

-0.0090

Avg Vol

54316

Mkt Cap

30035256

Exch

NASDAQ

Country

GB

Phone

44 20 8154 4600

DCF Diff

-2.7296

DCF

4.2096

Div Yield

0.0000

P/S

0.0000

EV Multiple

0.8996

P/FV

0.2555

Div Yield %

0.0000

P/E

-0.4599

PEG

-0.1196

Payout

0.0000

Current Ratio

8.2418

Quick Ratio

8.2418

Cash Ratio

6.6534

DSO

0.0000

DIO

0.0000

Op Cycle

0.0000

DPO

0.0000

CCC

0.0000

Gross Margin

0.0000

Op Margin

0.0000

Pretax Margin

0.0000

Net Margin

0.0000

Eff Tax Rate

-0.0074

ROA

-0.4889

ROE

-0.4736

ROCE

-0.6065

NI/EBT

1.0074

EBT/EBIT

0.8982

EBIT/Rev

0.0000

Debt Ratio

0.0321

D/E

0.0364

LT Debt/Cap

0.0000

Total Debt/Cap

0.0351

Int Coverage

0.0000

CF/Debt

-11.4092

Equity Multi

1.1361

Rec Turnover

0.0000

Pay Turnover

0.0000

Inv Turnover

0.0000

FA Turnover

0.0000

Asset Turnover

0.0000

OCF/Share

-1.1888

FCF/Share

-1.2096

Cash/Share

2.3568

OCF/Sales

0.0000

FCF/OCF

1.0175

CF Coverage

-11.4092

ST Coverage

-11.4092

CapEx Coverage

-57.2351

Div&CapEx Cov

-57.2351

P/BV

0.2555

P/B

0.2555

P/S

0.0000

P/E

-0.4599

P/FCF

-0.6153

P/OCF

-0.6149

P/CF

-0.6149

PEG

-0.1196

P/S

0.0000

EV Multiple

0.8996

P/FV

0.2555

DPS

0.0000

Latest Headlines (EST)

Revenue Product Segmentation